Cartilage Oligomeric Matrix Protein Shows High Affinity Zinc-dependent Interaction with Triple Helical Collagen*

Krisztina Rosenberg, Henric Olsson, Matthias Mörgelin, and Dick HeinegårdDagger

From the Department of Cell and Molecular Biology, Section of Connective Tissue Biology, Lund University, S-221 00 Lund, Sweden

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cartilage and tendon extracellular matrices are composed of collagens, proteoglycans, and a number of noncollagenous proteins. Cartilage oligomeric matrix protein (COMP) is a prominent such protein, structurally related to the thrombospondins. We found that native COMP binds to collagen I/II and procollagen I/II and that the interaction is dependent on the divalent cations Zn2+ or Ni2+, whereas Ca2+, Mg2+, and Mn2+ did not promote binding. Using a solid phase assay, Scatchard analysis identified one class of binding site with a dissociation constant (Kd) close to 1.5 nM in the presence of Zn2+. The results were confirmed by studies using surface plasmon resonance. Furthermore, metal chelate chromatography demonstrated that COMP bound Zn2+ and Ni2+. Electron microscopy showed that the interaction occurred at four defined sites on the 300-nm collagen and procollagen molecules. Two were located close to each end, and two at 126 and 206 nm, respectively, from the C-terminal. COMP interacted via its C-terminal globular domain and significantly only in the presence of Zn2+.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The major structural constituents of the ECM1 in cartilage are proteoglycans and collagens. One of the more prominent noncollagenous proteins is COMP. This protein was initially found in articular, nasal, and tracheal cartilage (1), but has later been isolated from tendon (2, 3), where also the corresponding mRNA was demonstrated (3). In the growth plate, COMP is primarily observed in the proliferative region, where it is prominent pericellularly (4, 5), indicating a role in cell growth and matrix development. In more developed articular cartilage, COMP is a major noncollagenous matrix component, primarily located interterritorialy, especially in the more superficial part of the tissue.2 This high expression of COMP in mature articular cartilage may be induced by the high mechanical load on the tissue. In support, a non-weight-bearing equine tendon shows considerably lower COMP levels than the contralateral weight-bearing one (3).

COMP was first isolated from bovine articular cartilage by extraction under denaturing conditions with 4 M guanidine HCl (1). Native COMP has been isolated from Swarm rat chondrosarcoma (6), bovine cartilage (7), and human articular cartilage (8) under mild nondenaturing conditions by extraction with 10 mM EDTA, indicating that the interaction of COMP with components of the ECM depends on divalent cations. Structurally, COMP is related to the thrombospondins (9), having the same molecular domain arrangement of a series of four type 2 (epidermal growth factor) repeat domains followed by seven type 3 domains (calcium binding). COMP, however, is a pentameric glycoprotein consisting of identical 86650 ± 163-Da subunits, each substituted with two N-linked oligosaccarides (10). The five monomers are joined by interactions between their N-terminal portions that form a cylindrical structure (6). The interactions involve the formation of a five-stranded coiled coil (11) from an alpha -helical domain at the N terminus and are stabilized by two disulfide bonds.3 This structure shows a remarkable similarity to proposed models for trans-membrane ion-channels (12), although the role for such a protein in the ECM remains an enigma. The alpha -helical oligomerization domain is followed by a flexible strand and, at the C-terminal, a globular domain (6) that shows homology to the thrombospondins (9). It is possible that the globular C termini form multimeric binding sites for the interaction with other ECM components.

Bovine (9) and human (13) COMP contain an RGD sequence although at different locations, indicating that COMP may mediate cell binding (7). Rat COMP, however, does not contain any RGD sequence (9), and the primarily interterritorial localization of the protein in adult human cartilage2 suggests that the promotion of cell binding is not a primary function of COMP. It is possible that the adhesive properties of COMP are indirect, mediated by an ECM interaction partner. In line, no cell surface receptor for COMP has been isolated. That COMP may have important functions in the ECM is illustrated by the fact that a mutation in the potentially Ca-binding domain has been shown to lead to impaired secretion and severe multiple epiphyseal dysplasia (14).

Collagens constitute a large family of molecules with some 20 different members. In cartilage and tendon collagens II and I, respectively, are major components. Collagens are rodlike molecules, composed of three alpha -chains forming a very stable triple-helical structure. Each polypeptide chain is largely made up of a repeating sequence of -Gly-X-Y-, where X often is proline and Y hydroxyproline (15). In collagens I and II, many such monomers are assembled in a very specific fashion into fibrils, which are stabilized by intra- and intermolecular cross-links (16). Obviously, the organization of collagen fibrils in the ECM is of fundamental importance to the structure and function of e.g. cartilage and tendon. In the tissue the collagen fibrils associate to form fibers, which, in turn, form a network that is stabilized by cross bridging molecules. These include other collagens, e.g. collagen IX in cartilage (17) as well as noncollagenous molecules such as decorin (18-21), fibromodulin (19, 22, 23) and lumican (24), all capable of specific binding to triple helical collagen. In this report we present new data showing that native COMP is a novel interaction partner for collagens and that the interaction requires specific divalent cations.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Isolation of COMP

Extractions-- Fresh adult bovine fetlock joint articular cartilage (120 g) obtained from the local slaughterhouse was homogenized on ice with a Polytron homogenizer in 10 volumes (ml/g) of preextraction buffer (phosphate-buffered saline containing proteinase inhibitor mix: 0.10 M epsilon -aminocaproic acid, 5 mM benzamidine hydrochloride, and 10 mM N-ethylmaleimide). The homogenate was preextracted for 1 h at 4 °C and centrifuged at 20,000 rpm (Beckman, JA 20 rotor) for 30 min at 4 °C. The pellet was resuspended in 10 volumes of the same buffer by brief homogenization, washed for 15 min at 4 °C, and centrifuged as above. COMP was extracted from the residue with 10 volumes (ml/g) of extraction buffer (preextraction buffer now containing 10 mM EDTA) overnight at 4 °C. The residue was reextracted for 15 min with 10 volumes (ml/g) of extraction buffer. Remaining proteins were extracted with 4 M guanidine HCl, 50 mM sodium acetate, 10 mM EDTA, pH 5.8, containing proteinase inhibitor mix. Aliquots of 50 µl from all extracts were analyzed for COMP by 4-16% SDS-PAGE (25) and Western blotting (26).

Chromatography-- The EDTA extracts containing COMP, were combined, diluted with an equal volume of 0.10 M Tris-HCl, pH 7.4 and applied to a 110-ml DEAE-Sepharose Fast Flow column (Pharmacia Biotech, Sweden) equilibrated with 70 mM NaCl, 50 mM Tris-HCl, pH 7.4. After washing with equilibration buffer, COMP was eluted with a 1000-ml, 70-400 mM linear NaCl gradient in the same buffer. Fractions of 10 ml were collected, and aliquots of 50 µl were analyzed by SDS-PAGE to identify COMP-containing fractions. Relevant fractions were combined, concentrated by ultrafiltration using a PM10 membrane (Amicon, Beverly, MA), diluted with an equal volume of distilled water and passed over a 5-ml heparin-Sepharose CL-6B column (Pharmacia Biotech, Sweden) equilibrated in 25 mM Tris-HCl, 0.15 M NaCl, pH 7.4 (TBS) to remove fibronectin and thrombospondin (7). The flow-through, containing COMP, was collected, concentrated by ultrafiltration using a PM10 membrane (Amicon), and transferred to 25 mM Tris-HCl, 2 mM EDTA, pH 8.0. The sample was applied to a 5 ml MonoQ column (Pharmacia Biotech, Sweden) equilibrated in 25 mM Tris-HCl, 2 mM EDTA, pH 8.0. After washing with equilibration buffer, COMP was eluted with a 30 ml, 0-0.5 M linear NaCl gradient in the buffer. Aliquots of 3 µl from each 1-ml fraction were analyzed for COMP by SDS-PAGE (25) and Western blotting (26). Protein concentrations were determined using the Coomassie Plus reagent (Pierce).

Collagens

Collagen II isolated from lathyritic rat chondrosarcoma tissue was kindly provided by S. Carlsén, Department of Cell and Molecular Biology, Lund University. Collagen I isolated after pepsin digestion from bovine skin (Vitrogen 100) was obtained from Celtrix (Santa Clara, CA). Procollagen I was isolated from calf tendon fibroblasts (27), with minor modifications, and was a gift from Charlotte Wiberg, Department of Cell and Molecular Biology, Lund University. Procollagen II prepared from matrix-free cells from chick embryo sternal cartilage (28) was a gift from Yoshio Hojima, Department of Biochemistry and Molecular Biology, Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA.

Solid Phase Assay

96-well plates were coated (200 µl/well) overnight at room temperature with 1 µg/ml collagen I and II dissolved in 0.1 M acetic acid, pH 2.5. After rinsing with 0.15 M NaCl, 0.05% Tween, the wells were blocked with 200 µl of 1 mg/ml ovalbumin in TBS for 1 h at room temperature. After rinsing as above, the collagen-coated wells were incubated for 1 h at room temperature with 5 µg/ml COMP diluted in TBS containing divalent ions, Zn2+, Ca2+, Mg2+, Mn2+, and Ni2+ from 0.04 to 2.56 mM. To further study the effects of Ca2+ we used 0.5 mM Zn2+ and varied the Ca2+ concentrations from 0.01 to 2.56 mM. For Scatchard analysis, constant coat concentrations of 20 µg/ml collagen and 0.5 mM Zn2+ in buffers were used with increasing concentrations of COMP, from 0.03125 to 16.0 µg/ml, which corresponds to 0.07 to 37 nM, using a calculated molecular mass for COMP pentamer of 433,250 Da (10). Bound COMP was detected using polyclonal rabbit anti-bovine COMP (1) followed by alkaline phosphate- conjugated swine anti-rabbit IgG using p-nitrophenyl phosphate as the chromogenic substrate and recording the absorbance at 405 nm.

Surface Plasmon Resonance Assay

The BIAcoreTM 2000 system (BIAcore AB, Sweden) was used to characterize the interaction and determine the Kd between COMP and collagen II. Pure COMP and collagen II, respectively, were immobilized at 25 °C at a flow of 5 µl/min. Briefly, a CM5 sensor chip (BIAcore AB, Uppsala, Sweden) with a carboxymethylated dextran surface was activated with 40 µl of a mixture of 50 mM N-hydroxysuccinimide and 200 mM N-ethyl-N'-(dimethylaminopropyl)carbodiimide. COMP (40 µl of 50 µg/ml) in 10 mM sodium citrate, 0.15 M NaCl, pH 3.2 or collagen II (40 µl of 100 µg/ml) in 10 mM sodium citrate, pH 5.0, were immobilized. One surface was used as blank containing no coupled protein. Remaining activated groups were blocked with 40 µl of 1 M ethanolamine in 0.1 M NaHCO3, 0.5 M NaCl, pH 8.3. The immobilization resulted in 840 resonance units for COMP and 3000 resonance units for collagen II (1000 resonance units = 1 ng/mm2) (29). The binding assay was initially optimized by varying the concentration of collagen II (0.18 to 3 µM, flow 5 µl/min, sample volume 20 µl), the flow (5-80 µl/min, concentration 0.38 µM, sample volume 40 µl) and the sample volume (50-250 µl, flow 80 µl/min, concentration 0.38 µM); in total, 15 different variables. Proteins remaining on the surface were eluted with 5 mM EDTA. In the first binding study, 12.5 µg/ml collagen II was pumped over the COMP and blank surfaces in TBS containing 1 mM ZnCl2, or 1 mM CaCl2 at a flow rate of 80 µl/min and a sample volume of 160 µl. In a second experiment 12.5 µg/ml COMP or, as a negative control, 10 µg/ml of ovalbumin were pumped over the collagen II and blank surfaces in TBS with 1 mM ZnCl2 at a flow rate of 20 µl/min and a volume of 20 µl. The BIA evaluation software version 2.1 were used to calculate the Kd of the binding (30).

Metal Chelate Affinity Chromatography

HiTrap chelating affinity columns, 1 ml, (Pharmacia Biotech, Sweden) were charged with Zn2+, Ca2+, Mg2+, Mn2+, and Ni2+ according to the manufacturer's instructions. Approximately 45 µg of COMP in 25 mM Tris-HCl, 0.5 M NaCl, pH 7.4 (start buffer), were applied after equilibration of the columns with the same buffer. The sample was recirculated at 16 µl/min on the column for 20 h at 15 °C. After washing with 5 ml of start buffer, bound COMP was eluted with 6 ml of 50 mM EDTA in start buffer followed by 5 ml of 7% acetic acid. Throughout the chromatographic steps, fractions of 1 ml were collected, precipitated with ethanol and analyzed by SDS-PAGE. The gels were scanned, and the acquired image analyzed by Gel Pro Analyzer software (Media Cybernetics, Silver Spring, MD).

Electron Microscopy

COMP-procollagen samples (about 50 µg/ml at a molar COMP:procollagen ratio of 1:8) and COMP-collagen samples (about 200 µg/ml at a molar COMP:collagen ratio of 1:2) were dialyzed overnight at 4 °C against 0.2 M ammonium formate, pH 7.4, containing 1 mM ZnCl2 or 1 mM EDTA. Glycerol spraying and rotary shadowing for electron microscopy were performed as described previously (31-33). Briefly, the samples were diluted to a final concentration of 10 µg/ml with appropriate volumes of 40% glycerol, sprayed onto freshly cleaved mica disks, dried in vacuo, and rotary shadowed with platinum/carbon by means of electron bombardment heating. Alternatively, complexes were subjected to negative staining prior to electron microscopy. Samples of the respective proteins were incubated in the dialysis buffer described above and allowed to react for 2 h at 4 °C. The samples were diluted to a final concentration of 2 µg/ml with 50 mM Tris-HCl, 0.15 M NaCl, pH 7.4. They were adsorbed onto carbon-coated grids for 1 min, washed with one drop of water, and stained with 0.75% uranyl formate. The grids were rendered hydrophilic by glow discharge in air. Samples were observed in a Jeol 1200 EX electron microscope operated at 60 kV accelerating voltage. Evaluation of the data from electron micrographs was done as described previously (34).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Isolation of COMP-- Bovine articular cartilage was sequentially extracted first with phosphate-buffered saline containing protease inhibitors and N-ethylmaleimide, followed by this buffer also containing 10 mM EDTA (6). To estimate the size of the EDTA-extractable pool of COMP, the tissue residue was further extracted with guanidine HCl (see "Experimental Procedures") to release remaining proteins. Some 40% of the total amount of COMP present in the tissue was recovered in the EDTA extract (not shown) as judged by the intensity of the bands upon SDS-PAGE (25) of the different extracts. The EDTA extract was fractionated by chromatography on Fast Flow DEAE-Sepharose, heparin-Sepharose, and MonoQ columns. The typical yield of native, EDTA-extracted COMP was approximately 0.2 mg/g of cartilage tissue (wet weight), and the final product appeared pure, without detectable non-COMP components as confirmed by SDS-PAGE (Fig. 1) and Western blotting (not shown).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   SDS-PAGE of purified COMP. COMP was purified from bovine articular cartilage by EDTA extraction and chromatography on DEAE-Sepharose, heparin-Sepharose, and MonoQ. Pentameric COMP (lane 1) and COMP reduced by beta -mercaptoethanol (lane 2) were analyzed by SDS-PAGE in 4-16% gradient gels and visualized by Coomassie staining.

Interaction between COMP and Collagens in a Solid Phase Assay-- Binding of COMP to collagens coated onto microtiter plates was demonstrated using an enzyme-linked immuosorbent assay procedure. To determine the optimal coating density, different concentrations of collagens I and II were adsorbed to the plate followed by addition of 5 µg/ml COMP in the presence of 1 mM Zn2+. The binding became saturated at a coating density of 1 µg/ml for the collagens (not shown), which was used in some of the subsequent experiments. The binding of COMP to ovalbumin, used to block unoccupied sites on the plastic surface, was negligible.

Effect of Divalent Cations-- In the nominal absence of divalent cations (1 mM EDTA) the binding that is seen in the presence of 1 mM Zn2+ was reduced to control levels (ovalbumin). Substitution of Zn2+ for Ca2+, Mg2+, or Mn2+ also reduced binding to control levels. Among the divalent cations tested, the interaction between COMP and collagens I and II displayed a preference for Zn2+ (Fig. 2, A and B), and the binding was saturated at 0.5 mM of Zn2+. Also Ni2+ promoted binding between COMP and these collagens, however less efficiently (70% of the binding obtained with Zn2+). To determine whether calcium ions had an inhibitory effect on the Zn2+-supported binding between COMP and collagen I and II, different concentrations of Ca2+ were combined with a constant concentration of 0.5 mM zinc. The binding was inhibited by approximately 40% at a calcium concentration of 1 mM but was not further inhibited at up to 5 times higher concentrations of calcium over zinc (Fig. 3).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2.   COMP binding to collagen I and II in the presence of divalent cations using solid phase assay. Collagens I (A) and II (B), respectively, were coated at 1 µg/ml in 0.1 M acetic acid, pH 2.5, on a 96-well polystyrene plate overnight and incubated for 1 h with 5 µg/ml COMP in 25 mM Tris-HCl, 0.15 M NaCl, pH 7.4, containing 0.04-2.56 mM of the divalent ions: Zn2+ (open circle ------open circle ), Ni2+ (------), Ca2+ (black-diamond ------black-diamond ), Mg2+ (black-square------black-square), and Mn2+ (bullet ------bullet ). Bound COMP was detected using a polyclonal rabbit anti-bovine COMP followed by alkaline phosphate-conjugated swine anti-rabbit IgG using p-nitrophenyl phosphate as the chromogenic substrate and recording absorbance at 405 nm. Data are means of quadruplicate determinations ± S.D.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   COMP binding to collagen I and II is affected by different ratios of Zn2+:Ca2+ in solid phase assay. Collagens I (black-square------black-square) and II (open circle ------open circle ), respectively, were coated 1 µg/ml in 0.1 M acetic acid, pH 2.5, on a 96-well polystyrene plate over night and incubated for 1 h with 5 µg/ml COMP in 25 mM Tris-HCl, 0.15 M NaCl, 0.5 mM ZnCl2, pH 7.4, also containing 0.01-2.56 mM CaCl2. Bound COMP was detected using a polyclonal rabbit anti-bovine COMP followed by alkaline phosphate-conjugated swine anti-rabbit IgG using p-nitrophenyl phosphate as the chromogenic substrate and recording absorbance at 405 nm. Data are means of quadruplicate determinations ± S.D.

Dissociation Constants-- To assess the strength of the interaction between COMP and collagens I and II the COMP concentration was varied in the presence of 0.5 mM Zn2+ and a coating density of 20 µg/ml of the respective collagen. Under these conditions the binding displayed saturation at approximately 15 nM COMP both for collagen II and for collagen I (Fig. 4, A and B). Scatchard analysis (35) of the data, assuming one class of binding site, demonstrated Kd values of 1.51 ± 0.25 nM for collagen I (Fig. 4A) and 1.72 ± 0.16 nM for collagen II (Fig. 4B).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 4.   COMP binding to collagen I and II in the presence of Zn2+ and their dissociation constants in solid phase assay. Collagens I (A, black-square------black-square) and II (B, open circle ------open circle ), respectively, were coated at 20.0 µg/ml in 0.1 M acetic acid, pH 2.5, on a 96-well polystyrene plate overnight and incubated with 0.37-190 nM COMP in 25 mM Tris-HCl, 0.15 M NaCl, 0.5 mM ZnCl2, pH 7.4, for 1 h to obtain binding saturation curves. Bound COMP was detected using a polyclonal rabbit anti-bovine COMP followed by alkaline phosphate-conjugated swine anti-rabbit IgG using p-nitrophenyl phosphate as the chromogenic substrate and recording absorbance at 405 nm. Inset, the values were analyzed by Scatchard plots to calculate the dissociation constant between COMP and collagen I and II. Data are means of quadruplicate determinations ± S.D.

Interaction between COMP and Collagen II Studied by Surface Plasmon Resonance-- This system was first optimized for COMP bound to the surface by adding collagen II in the presence of Zn2+. The calculated mean Kd value found for the 15 different experimental settings was 3.0 ± 1.5 nM. Further characterization of the interaction at the optimum binding conditions in the presence of Zn2+ or Ca2+ showed that no binding occurred between COMP and collagen II in the presence of Ca2+ (Fig. 5). The COMP-collagen II interaction could be demonstrated also in the reverse manner, i.e. by passing COMP over a collagen II surface in the presence of Zn2+, where ovalbumin, the negative control, did not bind (Fig. 5, inset).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   COMP binding to collagen II detected by surface plasmon resonance assay. COMP immobilized on a CM5 sensor chip was allowed to interact with 12.5 µg/ml collagen II in 25 mM Tris-HCl, 0.15 M NaCl, pH 7.4, in the presence of 1 mM ZnCl2, (------), or in the presence of 1 mM CaCl2 (- - - - -), injected with a flow of 80 µl/min and a volume of 160 µl. Inset, collagen II immobilized on a CM5 sensor chip interacts with 12.5 µg/ml COMP in 25 mM Tris-HCl, 0.15 M NaCl, 1 mM ZnCl2, pH 7.4 (------), but not with 10 µg/ml ovalbumin (- - - - -), injected with a flow of 20 µl/min and a volume of 20 µl.

COMPs Affinity for Divalent Cations-- To determine whether COMP had direct affinity for divalent metal ions, the protein was passed over metal chelate columns charged with Zn2+, Ca2+, Mg2+, Mn2+, and Ni2+. When applied to an uncharged column or to columns charged with Ca2+, Mg2+, or Mn2+, COMP did not bind and was recovered in the flow-through. COMP was retained on columns charged with Zn2+, and more than 50% of the applied protein was eluted with 50 mM EDTA (Fig. 6). COMP was retained also on a Ni2+ column. In this case, it did not elute with 50 mM EDTA, but elution required 7% acetic acid.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 6.   COMP binding to zinc upon zinc chelate affinity chromatography. COMP in 25 mM Tris, 0.5 M NaCl, pH 7.4 (TBS) was recirculated through a HiTrap column charged with zinc for 20 h. COMP was identified in column effluent fractions (black-square------black-square) by SDS-PAGE 4-16% gradient gel electrophoresis, and the bands were quantified by measuring the optical density (Gel Pro Analyzer). Fraction 1, flow-through; fractions 2-5, washed with TBS; fractions 6-11, COMP eluted with TBS with 50 mM EDTA, and fractions 12-15, 7% acetic acid.

Electron Microscopy-- Complexes between COMP and collagens were visualized by electron microscopy after spraying from glycerol/buffer mixtures and rotary shadowing (Fig. 7, A and B) as well as after adsorption to carbon films and negative staining (Fig. 7C). Both techniques produced images where the pentameric COMP structure, with its five globular C-terminal globules, and individual 300 nm collagen monomers could be clearly distinguished. Rotary shadowing images revealed COMP-collagen I/II complexes (Fig. 7A) and COMP-procollagen I/II complexes (Fig. 7B), respectively. A key observation was that only the C-terminal globule of COMP interacted with the collagen monomer. This was further underlined by negative staining of COMP-collagen I/II complexes, where the N-terminal oligomerization domain of COMP appeared more distinct and clearly distinguished from collagen filaments (Fig. 7C). By using procollagen it was possible to establish the polarity of the monomer, as the C-terminal propeptide adopted a globular conformation that was clearly visible in the micrographs (Fig. 7B). Statistical analysis of the binding of COMP to procollagen I/II in the presence of zinc revealed four binding sites situated at 0 (the C-terminal), 126, 206, and 300 nm (the N-terminal) (Fig. 8, A and B). The COMP molecules were roughly equally distributed between these sites, possibly with a slight preference for the C-terminal of procollagen I/II. In the presence of EDTA, i.e. in the nominal absence of Zn2+, the four sites still showed, distinguishable, although much reduced, preferential binding. However, considerable randomized binding occurred between the sites (Fig. 8, C and D), and the total number of collagen molecules containing bound COMP was reduced from 60% to 10%. The same analysis when applied to COMP-collagen I/II complexes yielded three apparent binding sites: at 0 nm, 94 nm and 126 nm (Fig. 9,A and B). This is consistent with the results obtained for procollagen, considering that it is not possible to determine the polarity of the collagen monomer. Again, substitution of Zn2+ for EDTA resulted in reduced relative binding at the specific binding sites and increased random binding (Fig. 9, C and D).


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 7.   COMP binding to collagen and procollagen in the presence of zinc or EDTA visualized by electron microscopy. COMP was incubated with collagen I or procollagen II during dialysis overnight against 0.2 M ammonium formate, pH 7.4, with 1 mM zinc or 1 mM EDTA for glycerol spraying/rotary shadowing or for 2 h for negative staining. The molar ratio COMP:collagen was 1:2 and COMP:procollagen 1:8. COMP binds via a globular end to the collagen filament and often bridges between different collagen I monomeric molecules (A, arrows). To identify the polarity of collagen, procollagen II was used as its C terminus seen as a globular domain (B, arrows). A and B were visualized after glycerol spraying/rotary shadowing. Visualization of the COMP/collagen I complexes at higher resolution after negative staining identifies the binding site on COMP as the C-terminal globular domain (C, arrows), and not the elongated N-terminal coiled-coil region (C, arrowheads). The bars represent 100 nm (A and B) and 50 nm (C).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 8.   COMP distribution along procollagens I and II in the presence of zinc or EDTA. COMP was incubated with procollagen I or II during dialysis overnight in 0.2 M ammonium formate, pH 7.4, with 1 mM zinc for glycerol spraying/rotary shadowing or for 2 h in the same buffer with 1 mM EDTA for negative staining. The molar ratio COMP:procollagen was 1:8. Interactions between COMP and procollagen I and II were in the presence of Zn2+ (A and B) or EDTA (C and D). The C-terminal of procollagen is at 0 nm and the N-terminal at 300 nm. The relative frequency denotes the fraction of COMP molecules which are bound to a given site on procollagen. Each bar corresponds to 1 nm.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 9.   COMP distribution along collagens I and II in the presence of zinc and EDTA. COMP was incubated with collagen I or II during dialysis overnight in 0.2 M ammonium formate, pH 7.4, with 1 mM zinc for glycerol spraying/rotary shadowing or for 2 h in the same buffer with 1 mM EDTA for negative staining. The molar ratio COMP:collagen was 1:8. COMP and collagen I/II interacted in the presence of Zn2+ (A and B) or EDTA (C and D). The C or N terminus of collagen is at 0 or 300 nm, as this cannot be defined. The relative frequency denotes the fraction of COMP molecules which are bound to a given site on collagen. Each bar corresponds to 1 nm.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In the present study we demonstrate that COMP, abundant in cartilage and tendon extracellular matrix, is a novel interaction partner for the fibril forming collagens I and II. This suggests that one function for COMP is to influence the organization of collagen fibrils, thereby contributing to tissue structure and function.

In preliminary experiments aiming at identifying ECM-components interacting with COMP, sulfate-labeled glycosaminoglycans from cultured bovine chondrocytes and Swarm rat chondrosarcoma cells were passed over COMP affinity columns. Persistently, proteoglycans, including aggrecan, biglycan, and fibromodulin, were bound to the column. However, using purified proteoglycans no COMP-proteoglycan interaction could demonstrate suggesting that the interaction was mediated by other components. The previously described interactions between small proteoglycans and collagens (19) prompted us to test for a direct binding between collagens and COMP. Indeed, such an interaction could be demonstrated and was shown to depend on the presence of divalent cations.

The observation that there is a large pool of COMP in cartilage that is readily extractable by physiological buffers containing EDTA (6), indicated that the anchorage of COMP in the ECM depends on divalent cations. This interpretation is corroborated by the present data that the binding of COMP to collagens I and II in a solid phase assay is promoted by Zn2+. On the other hand, the divalent cations Ca2+, Mg2+, and Mn2+ did not induce binding, and, if showing any effect, rather inhibited the weak residual binding between the proteins observed in the nominal absence of divalent metal ions (Fig. 2, A and B). Moreover, Ca2+ at a concentration of 2 mM did, although only partly, inhibit the COMP-collagen interaction induced by 0.5 mM Zn2+ (Fig. 3). Binding was not detected between COMP and collagen II in the presence Ca2+ with no Zn2+, in studies using surface plasmon resonance (Fig. 5).

Further characterization of the COMP-collagen interaction by Scatchard analysis was consistent with only one class of binding sites (Fig. 4, insets). The apparent dissociation constants were 1.51 ± 0.25 nM and 1.72 ± 0.16 nM for collagen I and II, respectively. The dissociation constant of 3.0 ± 1.5 nM found upon surface plasmon resonance analysis of the interaction between COMP and collagen II was comparable to the data from the solid phase assay. Clearly, the high affinity of the interaction strongly suggests that COMP and collagen may interact also in vivo, where they are found in the same interterritorial compartment of e.g. adult articular cartilage (4).

Metal chelate affinity chromatography revealed that COMP binds Zn2+ (Fig. 5) and Ni2+. Columns charged with Ca2+, Mg2+, and Mn2+ did not retain COMP (not shown), but as these ions are poorly chelated by the currently available chelating matrices the interpretation of the results is ambiguous. As a matter of fact, the observation that Ca2+ partly inhibited the binding induced by Zn2+, suggests that COMP can also bind Ca2+. This would be expected as the COMP monomer contains several putative Ca-binding epidermal growth factor-domains and calcium binding thrombospondin type 3 repeats (9). Two of the epidermal growth factor domains have amino acid sequences typical for calcium binding (36, 37). The thrombospondin type 3 repeats are rich in Asp and Asn, just like cadherins that are known calcium-binding proteins (38). Added to this, Cys and His are very common throughout the molecule, and these residues are known to coordinate divalent ions (39). Further indication that Zn2+ promotes the interaction by binding to COMP, rather than to collagen, is that the previously described interaction between fibromodulin and collagen I or II was totally unaffected by the presence of Zn2+ (not shown). As this interaction depends on the native structure of collagen (21), it is not likely that Zn2+ induces significant change in the collagen. We therefore suggest that the role of Zn2+ is to induce a conformation of COMP that promotes binding to collagen. The observation that Ca2+ only partially competes with the Zn2+-induced binding (Fig. 3) indicates that the two ions bind to different sites.

Visualization of the COMP-collagen complexes by electron microscopy clearly showed that it is the C-terminal globular part of COMP that mediates the interaction. Furthermore, statistical evaluation of the binding demonstrated the presence of four distinct binding sites on collagen (Fig. 7, A-C). The COMP molecules distributed rather equally between these sites, indicating their similar or equal affinities for COMP. This was corroborated by the Scatchard plot data and the surface plasmon resonance data indicating one type of strong binding. The use of procollagen made it possible to determine the polarity of the collagen monomer as the C-terminal propeptide appeared as a globule in the micrographs (Fig. 7B). With pepsin-extracted collagens, not containing the propeptides, the N and C termini could no longer be distinguished. Consequently, the four binding sites identified at 0 (C terminus), 126, 206, and 300 nm (N terminus) on procollagen were reduced to only three sites on collagen; one including the N and C termini at an end (Fig. 9, A and B). The fact that binding was observed at the ends of the filamentous part of procollagen as well as of pepsinized collagen can be taken to indicate that also these active sites are in the triple helical domain, since it is likely that the structures corresponding to the short telopeptides have quite a different conformation in procollagen. Another observation was that the binding at 126 nm from the C-terminal is located very near the fibronectin binding site, amino acids 757-791 (40), as well as the collagenase cleavage site, amino acids 775-776 (41). Some COMP-collagen complexes were still observed in the presence of EDTA, but the portion of COMP molecules engaged in specific binding was much reduced. In addition, the distribution of COMP along the collagen monomer became more randomized, although there was some preference for the four sites (Fig. 9, C and D). This residual binding, also observed in the solid phase assay, may be due to some Zn2+, or Ni2+, remaining bound to COMP even in the presence of EDTA, and, if so, indicates a very tight coordination of these ions by COMP.

The structurally related thrombospondin type 1 has similarly been shown to bind to collagens I-V at one end of the pepsinized, triple helical collagen, but in the presence of Ca2+ or EGTA (42, 43). It has also been shown that thrombospondin type 1 binds to Ca2+ (44) and that this binding can be inhibited to 40% by Zn2+ (45).

An important issue is whether these observations are physiologically relevant and one consideration is then the concentrations and relative abundance of divalent ions in cartilage. The concentrations of the divalent ions have been measured by different techniques, giving somewhat different results. In summary, concentrations of zinc ranging from 0.16 to 1.85 mM have been determined (46, 47) and calcium values reported range from 5 to 98 mM (47-51). It has been reported that the mass ratio between Ca2+ and Zn2+ is 5:1 in resting cartilage of the growth plate (52), but in articular cartilage the proportion is 50:1 (47). However, little is known about the distribution in the different layers and compartments in cartilage. It has been demonstrated that the proportion of divalent cations vary between different layers in epiphyseal growth cartilage (49), scapular growth cartilage (52), and in adult articular cartilage (47). This distribution is likely to be influenced by the molecular composition of the ECM. The overall concentrations of zinc shown for articular cartilage is well above the concentration critical for optimal COMP binding. On the other hand if the overall ratio of calcium to zinc is as high as around 50 (47), it is possible that local variations in this ratio may modulate COMP-collagen interactions. The notion that Zn2+ and Ni2+ may play important biological roles in cartilage organization is supported by the observation that these ion species appear to modulate the biochemical and functional properties of link protein in bovine articular cartilage (53).

COMP is an enigmatic protein that despite its high expression in cartilage has not been assigned a biological function. Its pentameric structure, though, offers the potential for multivalent interactions with other large structural tissue constituents. In this study we show that one such interaction partner for COMP appears to be triple-helical collagen. The strength of the interaction is such that it is likely to be relevant also in the tissue. Furthermore, we demonstrate that it is the globular C-terminal domains of COMP that mediate the interaction, underscoring that a primary functional feature of COMP is multivalent interactions with one or several collagen monomers. It appears that one COMP molecule can concomitantly bind to only one of the binding sites on a particular collagen molecule, as the total length of two subunits of COMP is only 56 ± 6 nm (6). This is too short to span the distance between any two sites on the collagen molecule, although COMP can bridge between such molecules. The novel interaction between COMP and collagens may have several roles in tissue homeostasis, including regulating collagen fibril formation and maintaining the properties and integrity of the collagen network.

    FOOTNOTES

* This work was supported by grants from Swedish Medical Research Council, the Royal Physiographic Society, Greta and Johan Kock's Foundation, Anna-Greta Crafoord's Foundation for Research on Rheumathology, Österlund's Foundation, Kung Gustav V's 80-års Found, and the Medical Faculty of the University of Lund.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Lund University, Department of Cell and Molecular Biology, Section for Connective Tissue Biology, P. O. Box 94, S-221 00 Lund, Sweden. Tel.: 46 46 222 8571; Fax: 46 46 211 3417; E-mail: Dick.Heinegard{at}medkem.lu.se.

The abbreviations used are: ECM, extracellular matrix; COMP, cartilage oligomeric matrix protein; PAGE, polyacrylamide gel electrophoresis.

2 P. Lorenzo and D. Heinegård, unpublished results.

3 A. Oldberg, personal communication.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Hedbom, E., Antonsson, P., Hjerpe, A., Aeschlimann, D., Paulsson, M., Rosa- Pimentel, E., Sommarin, Y., Wendel, M., Oldberg, A., and Heinegård, D. (1992) J. Biol. Chem. 267, 6132-6136[Abstract/Free Full Text]
  2. DiCesare, P. E., Hauser, N., Lehman, D., Pasumarti, S., and Paulsson, M. (1994) FEBS Lett. 354, 237-240[CrossRef][Medline] [Order article via Infotrieve]
  3. Smith, R. K. W, Zunino, L., Webbon, P. M., and Heinegård, D. (1997) Matrix Biol. 16, 255-271[CrossRef][Medline] [Order article via Infotrieve]
  4. Shen, Z., Heinegård, D., and Sommarin, Y. (1995) Matrix Biol. 14, 773-781[Medline] [Order article via Infotrieve]
  5. Ekman, S., Reinholt, F. P., Hultenby, K., and Heinegård, D. (1997) Calcif. Tissue Int. 60, 547-553[CrossRef][Medline] [Order article via Infotrieve]
  6. Mörgelin, M., Heinegård, D., Engel, J., and Paulsson, M. (1992) J. Biol. Chem. 267, 6137-6141[Abstract/Free Full Text]
  7. DiCesare, P. E., Mörgelin, M., Mann, K., and Paulsson, M. (1994) Eur. J. Biochem. 223, 927-937[Abstract]
  8. DiCesare, P. E., Mörgelin, M., Carlson, C. S., Pasumarti, S., and Paulsson, M. (1995) J. Orthop. Res. 13, 422-428[Medline] [Order article via Infotrieve]
  9. Oldberg, A., Antonsson, P., Lindblom, K., and Heinegård, D. (1992) J. Biol. Chem. 267, 22346-22350[Abstract/Free Full Text]
  10. Zaia, J., Boynton, R. E., McIntosh, A., Marshak, D. R., Olsson, H., Heinegård, D., and Barry, F. P. (1997) J. Biol. Chem. 272, 14120-14126[Abstract/Free Full Text]
  11. Efimov, V. P., Lustig, A., and Engel, J. (1994) FEBS Lett. 341, 54-58[CrossRef][Medline] [Order article via Infotrieve]
  12. Malashkevich, V. N., Kammerer, R. A., Efimov, V. P., Schulthess, T., and Engel, J. (1996) Science 274, 761-765[Abstract/Free Full Text]
  13. Newton, G., Weremowicz, S., Morton, C. C., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., and Lawler, J. (1994) Genomics 24, 435-439[CrossRef][Medline] [Order article via Infotrieve]
  14. Briggs, M. D., Hoffman, S. M., King, L. M., Olsen, A. S., Mohrenweiser, H., Leroy, J. G., Mortier, G. R., Rimoin, D. L., Lachman, R. S., Gaines, E. S., Cekleniak, J. A., Knowlton, R. G., and Cohn, D. H. (1995) Nat. Genet. 10, 330-336[Medline] [Order article via Infotrieve]
  15. Bornstein, P., and Traub, W. (1979) in The Proteins (Neurath, H., and Hill, R. L., eds), pp. 411-632, Academic Press, New York
  16. Kühn, K. (1987) in Structure and Function of Collagen Types (Mayne, R., and Burgeson, R. E., eds), pp. 1-42, Academic Press, New York
  17. van der Rest, M., and Mayne, R. (1988) J. Biol. Chem. 263, 1615-1618[Abstract/Free Full Text]
  18. Vogel, K. G., Paulsson, M., and Heinegård, D. (1984) Biochem. J. 223, 587-597[Medline] [Order article via Infotrieve]
  19. Hedbom, E., and Heinegård, D. (1989) J. Biol. Chem. 264, 6898-6905[Abstract/Free Full Text]
  20. Pringle, G. A., and Dodd, C. M. (1990) J. Histochem. Cytochem. 38, 1405-1411[Abstract]
  21. Svensson, L., Heinegård, D., and Oldberg, A. (1995) J. Biol. Chem. 270, 20712-20716[Abstract/Free Full Text]
  22. Hedbom, E., and Heinegård, D. (1993) J. Biol. Chem. 268, 27307-27312[Abstract/Free Full Text]
  23. Hedlund, H., Mengarelli Widholm, S., Heinegård, D., Reinholt, F. P., and Svensson, O. (1994) Matrix Biol. 14, 227-232[CrossRef][Medline] [Order article via Infotrieve]
  24. Rada, J. A., Cornuet, P. K., and Hassell, J. R. (1993) Exp. Eye Res. 56, 635-648[CrossRef][Medline] [Order article via Infotrieve]
  25. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  26. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract]
  27. Kadler, K. E., Hojima, Y., and Prockop, D. J. (1987) J. Biol. Chem. 262, 15696-15701[Abstract/Free Full Text]
  28. Curran, S., and Prockop, D. J. (1982) Biochemistry 21, 1482-1487[Medline] [Order article via Infotrieve]
  29. Stenberg, E., Persson, B., Roos, H., and Urbaniczky, C. (1991) Colloid Interface Sci. 143, 513-526
  30. Fägerstam, L. G., Frostell Karlsson, A., Karlsson, R., Persson, B., and Ronnberg, I. (1992) J. Chromatogr. 597, 397-410[CrossRef][Medline] [Order article via Infotrieve]
  31. Shotton, D. M., Burke, B. E., and Branton, D. (1979) J. Mol. Biol. 131, 303-329[Medline] [Order article via Infotrieve]
  32. Fowler, W. E., and Erickson, H. P. (1979) J. Mol. Biol. 134, 241-249[Medline] [Order article via Infotrieve]
  33. Tyler, J. M., and Branton, D. (1980) J. Ultrastruct. Res. 71, 95-102[Medline] [Order article via Infotrieve]
  34. Engel, J., and Furthmayr, H. (1987) Methods Enzymol. 145, 3-78[Medline] [Order article via Infotrieve]
  35. Scatchard, G. (1949) Ann. N. Y. Acad. Sci. 51, 660-672
  36. Handford, P. A., Mayhew, M., Baron, M., Winship, P. R., Campbell, I. D., and Brownlee, G. G. (1991) Nature 351, 164-167[CrossRef][Medline] [Order article via Infotrieve]
  37. Stenflo, J., Ohlin, A. K., Persson, E., Valcarce, C., Astermark, J., Drakenberg, T., Selander, M., Linse, S., and Björk, I. (1991) Ann. N.Y. Acad. Sci. 614, 11-29[Medline] [Order article via Infotrieve]
  38. Ozawa, M., Engel, J., and Kemler, R. (1990) Cell 63, 1033-1038[Medline] [Order article via Infotrieve]
  39. Arnold, F. H., and Haymore, B. L. (1991) Science 252, 1796-1797[Medline] [Order article via Infotrieve]
  40. Dzamba, B. J., Wu, H., Jaenisch, R., and Peters, D. M. (1993) J. Cell Biol. 121, 1165-1172[Abstract]
  41. Li, J., Brick, P., O'Hare, M. C., Skarzynski, T., Lloyd, L. F., Curry, V. A., Clark, I. M., Bigg, H. F., Hazleman, B. L., Cawston, T. E., and Blow, D. M. (1995) Structure 3, 541-549[Medline] [Order article via Infotrieve]
  42. Lawler, J., Connolly, J. E., Ferro, P., and Derick, L. H. (1986) Ann. N. Y. Acad. Sci. 485, 273-287[Medline] [Order article via Infotrieve]
  43. Galvin, N. J., Vance, P. M., Dixit, V. M., Fink, B., and Frazier, W. A. (1987) J. Cell Biol. 104, 1413-1422[Abstract]
  44. Lawler, J., and Simons, E. R. (1983) J. Biol. Chem. 258, 12098-12101[Abstract/Free Full Text]
  45. Misenheimer, T. M., and Mosher, D. F. (1995) J. Biol. Chem. 270, 1729-1733[Abstract/Free Full Text]
  46. Schor, R. A., Prussin, S. G., Jewett, D. L., Ludowieg, J. J., and Bhatnagar, R. S. (1973) Clin. Orthop. 93, 346-355[Medline] [Order article via Infotrieve]
  47. Rizzo, R., Grandolfo, M., Godeas, C., Jones, K. W., and Vittur, F. (1995) J. Exp. Zool. 273, 82-86[Medline] [Order article via Infotrieve]
  48. Maroudas, A. (1979) in Adult Articular Cartilage (Freeman, M. A. K., ed), pp. 215-290, Pitman Press, Bath, UK
  49. Hargest, T. E., Gay, C. V., Schraer, H., and Wasserman, A. J. (1985) J. Histochem. Cytochem. 33, 275-286[Abstract]
  50. Pritzker, K. P., Chateauvert, J. M., and Grynpas, M. D. (1987) J. Rheumatol. 14, 806-810[Medline] [Order article via Infotrieve]
  51. Chateauvert, J., Pritzker, K. P., Kessler, M. J., and Grynpas, M. D. (1989) J. Rheumatol. 16, 1098-1104[Medline] [Order article via Infotrieve]
  52. Vittur, F., Tuniz, C., Paoletti, S., Rizzo, R., and Jones, K. W. (1992) Biochem. Biophys. Res. Commun. 188, 1010-1017[Medline] [Order article via Infotrieve]
  53. Rosenberg, L., Choi, H. U., Tang, L. H., Pal, S., Johnson, T., Lyons, D. A., and Laue, T. M. (1991) J. Biol. Chem. 266, 7016-7024[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.